Company intelligence / Profile preview

ODI Medical

Ownership: Private
Development stage: Other

Overview

ODI Medical has developed and commercialized a patented, portable, non-invasive medical device—ODI-Tech®—for bedside evaluation of local hemoglobin oxygen saturation and perfusion. The device is FDA 510(k) cleared for use in the United States. It enables clinicians to assess microcirculation in individuals at risk of ischemic events or circulatory failure. The underlying technology is based on over 30 years of clinical research by founder Professor Knut Kvernebo. Clinical results have been published in peer-reviewed journals demonstrating its utility for quantifying human microcirculation.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Intent to work with leading stakeholders for further development

Beyond the preview

Go deeper on ODI Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ODI Medical.

Explore the full profile